From staff reports

Because of the drug shortage crisis, the Centers for Disease Control and Prevention (CDC) reminded healthcare providers this week that ?single dose? or ?single use? medications can be used for only one patient.

Omnicare today said it will pay the U.S. government $50 million in a civil settlement over the Drug Enforcement Administration?s claims that certain Omnicare pharmacies had errors and deficiencies in dispensing controlled substances.

Rivaroxaban, an oral blood thinner, is equally effective as standard therapy for the treatment of pulmonary embolism and may cause fewer bleeding complications, according to new data

The risk of Clostridium difficile infection among households is too low to justify interventions, other than avoiding unnecessary antimicrobials, according to a new study, published in April?s Journal of Infection.

The majority (90% to 98%) of sinus infections are caused by viruses and should not be treated with antibiotics, according to new guidelines from the Infectious Diseases Society of America.

Switching patients with rheumatoid arthritis to rituximab (Rituxan, Genentech) may be more effective than switching them to a second alternative anti-tumor necrosis factor (anti-TNF) after a first anti-TNF therapy has failed, according to a study published online in Arthritis Care & Research.